AUTO-GENERATED · CITATION-ONLY · 2026-10-29
$INSM — convergence catalyst
Convergence score: 48.5 ·
Signals fired: 14
(inflection;alpha;earnings;finra_short;clinical;xbrl_ni;biotech;sec_fda;gamma;earnings_catalyst;auto_macro_adp_payrolls;auto_macro_durable_goods;auto_macro_eia_petroleum;auto_macro_yield_curve) ·
Conviction: HIGH
Auto-generated from public filings. This is not financial advice.
Confirm independently before trading. Catalyst Edge holds positions consistent
with our published signals — see
trust report.
Citation block only. Automated narrative unavailable this cycle (reason: no_citations_in_summary).
Sources
- [1] SEC EDGAR · 10-Q filing on 2026-10-29 · 2026-10-29T07:00:38
- [2] SEC EDGAR · 10 filing on 2026-10-29 · 2026-10-29T07:00:38
- [3] Catalyst Edge convergence detector · Convergence score 48.5, 14 signals fired: inflection, alpha, earnings, finra_short, clinical, xbrl_ni, biotech, sec_fda, gamma, earnings_catalyst, auto_macro_adp_payrolls, auto_macro_durable_goods, auto_macro_eia_petroleum, auto_macro_yield_curve · 2026-10-29T15:12:45
Underlying signal breakdown
| Field | Value |
| convergence_score | 48.5 |
| conviction_level | HIGH |
| signal_count | 14 |
| sector | biotech |
| price | |
⚠️ Position disclosure: Catalyst Edge holds
a small live equity position in tickers that pass the convergence + scoop
publish gate. Real-time P/L, fills, and the running ledger are public at
/trust/. Specific entry
on
INSM: see
/scoreboard/
for outcome tracking. Bloomberg legally cannot disclose this; we do.